Material and Methods

Apparatus
A standard "AutoAnalyzer" (Technicon Corp., Tarrytown, N. Y. 10591) is used, including a Technicon Fluorometer II. The sample are analyzed at a rate of 60 per hour, with a 1:2 sample-to-wash ratio.
A Technicon "type c" membrane is used in the dialyzer and is changed every day. The delay coil is 26 m long, 1.6mm i.d.
Reagents
Saline. Dissolve 9 g of NaC1 in water. Add 1 ml of "Brij 35" (30 g/100 ml) and dilute to 1 liter with water.
Tris bailer
[tris (hydroxymethyl) 
Results
Nonspecific fluorescence.
Although there is no detectable galactose in the blood of normal infants (4), each sample gives a small peak, reflecting a small nonspecific fluorescence inherent to the technique. Depending on the actual activity of the commercial enzyme preparation, the relative nonspecific fluorescence may vary from one day to another.
The nonspecific peaks illustrated in Figure 2 gave a mean of 8 mg/iOO ml and a standard deviation of 1.8 for apparent galactose in 36 samples the day it was recorded.
This nonspecific fluorescence, which is almost constant from one sample to another, permits samples to be identified by numbering the peaks. Nevertheless, to each sample and standard is added galactose (final concentration, 10 mg/i00 ml), which allows the rate of analysis to be increased to 60 per hour without serious loss of resolution.
Without added galactose, sample peaks that are low and do not return to baseline at the 60 per hour rate are sometimes difficult to identify. The heavy line at 15% transmittance in Figure 2 should then be considered as the real baseline because of this added galactose.
Sometimes the nonspecific fluorescence may be quite high in a given sample, but on repeated determination returns to normal. A positive result is considered confirmed only after at least two determinations. Peaks a and b in Figure 2 are determinations from blood spots, made after adding 40 and 80 mg, respectively, of galactose per 100 ml of blood. They were analyzed five days after they were made, which is the mean transit time (time between the blood collection and the analysis) for our screening program.
The results for samples a and b were 31 and 57 mg/100 ml, respectively. For more security, the threshold can be reduced to less than 20 mg/100 ml by adding more commercial enzyme thus increasing sensitivity and cost of the method.
The limit of 20 mg/100 ml may be too high unless the specimen be obtained one or two hours after a feeding, since fasting levels of 3 mg/100 ml have been described in kinase and epimerase deficiencies. In our program until now, no effort has been made to obtain postprandial specimens. The original method (4) not only required samples of inconvenient volume, but was four times as costly and 25-fold less sensitive.
It must be remembered that because of nonspecific fluorescence, it should not be decided that the test is positive without at least a second determination.
We believe this low-cost, high-capacity method will be useful in determining the incidence of galactose disorders in different populations.
